✦ LIBER ✦

RITZ 5: Randomized intravenous TeZosentan (an endothelin ET-A/B antagonist) for the treatment of pulmonary edema: a prospective multicenter double blind Placebo controlled study

✍ Scribed by Edo Kaluski; Reuven Tzimilchman; Alon Marmur; Oscar Krakov; Olga Milovanov; Avi Caspi; Zvi Vered; Gad Cotter

Book ID: 119544290
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 151 KB
Volume: 39
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)80740-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RITZ-5: randomized intravenous TeZosenta

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema. A prospective, multicenter, double-blind, placebo-controlled study

✍ E. Kaluski; I. Kobrin; R. Zimlichman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 36 KB

RITZ-5: randomized intravenousTeZosentan

RITZ-5: randomized intravenousTeZosentan (an endothelin-A/B antagonist)for the treatment of pulmonary edema: A prospective, multicenter, double-blind, placebo-controlled study

✍ Edo Kaluski; Isaac Kobrin; Reuven Zimlichman; Alon Marmor; Oscar Krakov; Olga Mi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

A multicenter, prospective, randomized,

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A

The effect of ofloxacin on bacillus calm

The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study: Colombel M, Saint F, Chopin D, Malavaud B, Nicolas L, Rischmann P, Service d’Urologie et Chirurgie de la Transplantation, Hôpital Edouard Herriot, Universite Claude Bernard, 5, France

✍ H. Barton Grossman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 35 KB